Identifying long-term memory B-cells in vaccinated children despite waning antibody levels specific for Bordetella pertussis proteins

Vaccine

Volumn 29, Issue 7, 2011, Pages 1431-1437

  Hendrikx, Lotte H ^a,b   Öztürk, Kemal ^a   de Rond, Lia G H ^a   Veenhoven, Reinier H ^b   Sanders, Elisabeth A M ^c   Berbers, Guy A M ^a   Buisman, Anne Marie ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b Department of Orthopaedic Surgery   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Children; Memory B cells; Pertussis

Indexed keywords

ANTIBODY; BACTERIAL PROTEIN; DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEMAGGLUTININ; HEMAGGLUTININ PERTACTIN PERTUSSIS VACCINE; IMMUNOGLOBULIN G; PERTACTIN; PERTUSSIS TOXIN; PERTUSSIS VACCINE; TETANUS TOXOID; TRIPLE VACCINE; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; ARTICLE; BORDETELLA PERTUSSIS; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; GROUPS BY AGE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MEMORY CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; VACCINATION;

ANTIBODIES, BACTERIAL; ANTIBODY FORMATION; B-LYMPHOCYTES; BORDETELLA PERTUSSIS; CHILD; CHILD, PRESCHOOL; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; HAEMOPHILUS VACCINES; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN G; IMMUNOLOGIC MEMORY; TETANUS; WHOOPING COUGH;

EID: 79151470023     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.12.033     Document Type: Article

References (39)

1. de Greeff S.C., Mooi F.R., Schellekens J.F., de Melker H.E. Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands. Pediatr Infect Dis J 2008, 27(3):218-223.
2. Schellekens J., von Konig C.H., Gardner P. Pertussis sources of infection and routes of transmission in the vaccination era. Pediatr Infect Dis J 2005, 24(Suppl. 5):S19-S24.
3. Wirsing von Konig C.H., Postels-Multani S., Bock H.L., Schmitt H.J. Pertussis in adults: frequency of transmission after household exposure. Lancet 1995, 346(8986):1326-1329.
4. Canthaboo C., Williams L., Xing D.K., Corbel M.J. Investigation of cellular and humoral immune responses to whole cell and acellular pertussis vaccines. Vaccine 2000, 19(6):637-643.
5. Mahon B.P., Brady M.T., Mills K.H. Protection against Bordetella pertussis in mice in the absence of detectable circulating antibody: implications for long-term immunity in children. J Infect Dis 2000, 181(6):2087-2091.
6. Olin P., Rasmussen F., Gustafsson L., Hallander H.O., Heijbel H. Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines. Lancet 1997, 350(9091):1569-1577.
7. Buisman A.M., de Rond C.G., Ozturk K., Ten Hulscher H.I., van Binnendijk R.S. Long-term presence of memory B-cells specific for different vaccine components. Vaccine 2009, 28(1):179-186.
8. van Gageldonk P.G., van Schaijk F.G., van der Klis F.R., Berbers G.A. Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus. J Immunol Methods 2008, 335(1-2):79-89.
9. Baughman A.L., Bisgard K.M., Edwards K.M., Guris D., Decker M.D., Holland K., et al. Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States. Clin Diagn Lab Immunol 2004, 11(6):1045-1053.
10. de Melker H.E., Versteegh F.G., Conyn-Van Spaendonck M.A., Elvers L.H., Berbers G.A., van Der Zee A., et al. Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J Clin Microbiol 2000, 38(2):800-806.
11. Wirsing von Konig C.H., Gounis D., Laukamp S., Bogaerts H., Schmitt H.J. Evaluation of a single-sample serological technique for diagnosing pertussis in unvaccinated children. Eur J Clin Microbiol Infect Dis 1999, 18(5):341-345.
12. Amanna I.J., Carlson N.E., Slifka M.K. Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med 2007, 357(19):1903-1915.
13. Pinna D., Corti D., Jarrossay D., Sallusto F., Lanzavecchia A. Clonal dissection of the human memory B-cell repertoire following infection and vaccination. Eur J Immunol 2009, 39(5):1260-1270.
14. Crotty S., Aubert R.D., Glidewell J., Ahmed R. Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J Immunol Methods 2004, 286(1-2):111-122.
15. Crotty S., Felgner P., Davies H., Glidewell J., Villarreal L., Ahmed R. Cutting edge: long-term B cell memory in humans after smallpox vaccination. J Immunol 2003, 171(10):4969-4973.
16. Tuaillon E., Tabaa Y.A., Petitjean G., Huguet M.F., Pajeaux G., Fondere J.M., et al. Detection of memory B lymphocytes specific to hepatitis B virus (HBV) surface antigen (HBsAg) from HBsAg-vaccinated or HBV-immunized subjects by ELISPOT assay. J Immunol Methods 2006, 315(1-2):144-152.
17. Rojas O.L., Narvaez C.F., Greenberg H.B., Angel J., Franco M.A. Characterization of rotavirus specific B cells and their relation with serological memory. Virology 2008, 380(2):234-242.
18. Sasaki S., Jaimes M.C., Holmes T.H., Dekker C.L., Mahmood K., Kemble G.W., et al. Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines. J Virol 2007, 81(1):215-228.
19. Ward S.M., Phalora P., Bradshaw D., Leyendeckers H., Klenerman P. Direct ex vivo evaluation of long-lived protective antiviral memory B cell responses against hepatitis B virus. J Infect Dis 2008, 198(6):813-817.
20. Kelly D.F., Snape M.D., Cutterbuck E.A., Green S., Snowden C., Diggle L., et al. CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells. Blood 2006, 108(8):2642-2647.
21. Clutterbuck E.A., Oh S., Hamaluba M., Westcar S., Beverly P.C.L., Pollard A.J. Serotype specific and age dependent generation of pneumococcal polysaccharide specific memory B cells and antibody response to immunization with a pneumococcal conjugate vaccine. Clin Vaccine Immunol 2007, 15(2):182-193.
22. Blanchard Rohner G., Snape M.D., Kelly D.F., John T., Morant A., Yu L.M., et al. The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response. J Immunol 2008, 180(4):2165-2173.
23. Hallander H.O., Gustafsson L., Ljungman M., Storsaeter J. Pertussis antitoxin decay after vaccination with DTPa. Response to a first booster dose 3 1/2-6 1/2 years after the third vaccine dose. Vaccine 2005, 23(46-47):5359-5364.
24. Guiso N., Njamkepo E., Vie le Sage F., Zepp F., Meyer C.U., Abitbol V., et al. Long-term humoral and cell-mediated immunity after acellular pertussis vaccination compares favourably with whole-cell vaccines 6 years after booster vaccination in the second year of life. Vaccine 2007, 25(8):1390-1397.
25. Hendrikx L.H., Berbers G.A., Veenhoven R.H., Sanders E.A., Buisman A.M. IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content. Vaccine 2009, 27(47):6530-6536.
26. Edelman K., He Q., Makinen J., Sahlberg A., Haanpera M., Schuerman L., et al. Immunity to pertussis 5 years after booster immunization during adolescence. Clin Infect Dis 2007, 44(10):1271-1277.
27. Giuliano M., Mastrantonio P., Giammanco A., Piscitelli A., Salmaso S., Wassilak S.G. Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis. J Pediatr 1998, 132(6):983-988.
28. Zepp F., Knuf M., Habermehl P., Schmitt H.J., Meyer C., Clemens R., et al. Cell-mediated immunity after pertussis vaccination and after natural infection. Dev Biol Stand 1997, 89:307-314.
29. Tran Minh N.N., He Q., Edelman K., Olander R.M., Viljanen M.K., Arvilommi H., et al. Cell-mediated immune responses to antigens of Bordetella pertussis and protection against pertussis in school children. Pediatr Infect Dis J 1999, 18(4):366-370.
30. Rieber N., Graf A., Belohradsky B.H., Hartl D., Urschel S., Riffelmann M., et al. Differences of humoral and cellular immune response to an acellular pertussis booster in adolescents with a whole cell or acellular primary vaccination. Vaccine 2008, 16:6929-6935.
31. Kelly D.F., Pollard A.J., Moxon E.R. Immunological memory: the role of B cells in long-term protection against invasive bacterial pathogens. JAMA 2005, 294(23):3019-3023.
32. Thalen M., van der Ark A., van den Ijssel J., van Straaten I., Jansen D., Beuvery C., et al. Improving the cellular pertussis vaccine: increased potency and consistency. Vaccine 2008, 26(5):653-663.
33. Nanan R., Heinrich D., Frosch M., Kreth H.W. Acute and long-term effects of booster immunisation on frequencies of antigen-specific memory B-lymphocytes. Vaccine 2001, 20(3-4):498-504.
34. Kline G.H., Hayden T.A., Klinman N.R. B cell maintenance in aged mice reflects both increased B cell longevity and decreased B cell generation. J Immunol 1999, 162(6):3342-3349.
35. Huck K., Feyen O., Ghosh S., Beltz K., Bellert S., Niehues T. Memory B-cells in healthy and antibody-deficient children. Clin Immunol 2009, 131(1):50-59.
36. van Gent R., van Tilburg C.M., Nibbelke E.E., Otto S.A., Gaiser J.F., Janssens-Korpela P.L., et al. Refined characterization and reference values of the pediatric T- and B-cell compartments. Clin Immunol 2009, 133(1):95-107.
37. Siegrist C.A., Aspinall R. B-cell responses to vaccination at the extremes of age. Nat Rev Immunol 2009, 9(3):185-194.
38. Traggiai E., Puzone R., Lanzavecchia A. Antigen dependent and independent mechanisms that sustain serum antibody levels. Vaccine 2003, 21(Suppl. 2):S35-S37.
39. Bernasconi N.L., Traggiai E., Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 2002, 298(5601):2199-2202.